Impact of fibrin in high sensitivity cardiac troponin (Hs-cTn) detection: Implications for quality control

Chijioke Noris Ezinwa1

  • 1Department of Medical Laboratory Science, Faculty of Health Sciences and Technology, College of Medicine, University of Nigeria, Enugu Campus, Nigeria.

Insights

Fibrin clots can cause false positives in high-sensitivity troponin (hs-cTn) tests for acute myocardial infarction (AMI). This review highlights quality control needs and technological solutions to ensure accurate cardiac diagnosis.

Area of Science:

  • Clinical Chemistry
  • Cardiology
  • Biomedical Science

Background:

  • High-sensitivity troponin (hs-cTn) assays are vital for diagnosing acute myocardial infarction (AMI).
  • Fibrin clots and other factors can interfere with hs-cTn assays, leading to inaccurate results.
  • Accurate diagnosis is critical in emergency cardiac care.

Purpose of the Study:

  • To review the impact of fibrin clot detection on hs-cTn testing accuracy.
  • To emphasize the need for quality control in emergency cardiac testing.
  • To identify technological solutions for improving diagnostic accuracy.

Main Methods:

  • Critical literature review.
  • Evaluation of fibrin clot implications in hs-cTn testing.
  • Comparative analysis of auto-analysers for interference detection.

Main Results:

  • Biomedical scientists must prevent pre-analytical fibrin formation.
  • Steps are outlined to confirm hs-cTn diagnostic accuracy when fibrin is present.
  • Technological advancements can help detect fibrin and other interferences.
  • Limitations of current digital analysers in assessing procedural and outcome quality were identified.

Conclusions:

  • Robust quality control is essential to prevent false-positive hs-cTn results due to fibrin.
  • Technological solutions and careful pre-analytical procedures are key to accurate myocardial infarction diagnosis.
  • Further advancements are needed to overcome analyser limitations in diagnostic quality assurance.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
334
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
214
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
72